Bryan Kay
CVRx announces initiation of BENEFIT-HF trial of Barostim device in “significantly expanded population”
CVRx recently announced the start of the BENEFIT-HF clinical trial, a randomised study designed ...
CMS finalises coverage decision for renal denervation systems
The Centers for Medicare & Medicaid Services (CMS) has finalised its National Coverage Determina...
Terumo announces US FDA clearance for OpusWave imaging system
Terumo Interventional Systems has received 510(k) clearance from the U.S. Food and Drug Administrati...
Interim RAPID-PE study reveals ‘excellent’ safety data in first 50 patients
Prespecified interim analysis data from the first 50 patients in RAPID-PE have demonstrated "exc...
FDA begins ‘real-time’ reporting of adverse event data
The Food and Drug Administration (FDA) recently announced that it has begun daily publication of...
SCAI, SIR, SVS jointly publish proceedings from multispecialty peripheral IVUS roundtable
Proceedings from an expert consensus roundtable that discussed the benefits of intravascular ult...
VIVA 2021: Consensus established for appropriate use of IVUS in peripheral interventions
A worldwide committee of 40 cross-specialty medical experts achieved the first-ever consensus fo...
